Introduction and Objective:
Limited information exists in the recent literature capturing real- world utilization and cost of bypassing agents among hemophiliac patients with inhibitors in the US. The present study compared the…
Objective:
To assess quality of life, self-reported comorbidities, health-related quality of life (HRQoL), and impact of hemophilia on activities of young adult (YA) patients with hemophilia (PWH).
Methods:…
Objective:
To assess impact of hemophilia on relationships and employment during the transition to adulthood in young adult (YA) patients with hemophilia (PWH).
Methods:
Analysis of US YA-PWH respondents (…
Objective:
To assess treatment of young adult (YA) patients with hemophilia (PWH) and issues around access to and use of factor and comprehensive care.
Methods:
Analysis of US respondents aged 18-30 years…
Objective:
To evaluate changes in healthcare resource utilization and haemophilia related events among patients diagnosed with haemophilia A between 2008 and 2012.
Methods:
This retrospective study analyzed…
Objectives:
The objective of this study was to compare the rate of prophylaxis between severe hemophilia B and severe hemophilia A patients.
Methods:
A retrospective cross sectional study was conducted…
Objective:
Having a family member with a chronic disease often increases the burden in the family with more hospital visits, treatment administration, and increased expenses. Management of hemophilia patients with inhibitors can…
Objective:
To investigate the prevalence of comorbidities among adults with hemophilia in the Hemophilia Utilization Group Studies (HUGS)
Methods:
Standardized interviews were conducted for two prospective…
Objective:
Haemophilia A is an X-linked recessive bleeding disorder that affects males. Emerging data support evidence for increased bleeding in female haemophilia A carriers, and more haemophilia carriers are seeking care in…